CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
Rhea-AI Summary
CorMedix Therapeutics (Nasdaq: CRMD) announced that senior management will participate in a fireside chat and investor meetings at the Wells Fargo 21st Annual Healthcare Conference in Boston, held on September 8–10, 2026. The fireside chat webcast is scheduled for Wednesday, September 9, 2026, at 12:45 p.m. EDT, with a replay available on the company’s investor relations website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 13 | Q2 earnings | Positive | +14.5% | Revenue growth, raised EBITDA guidance, and expanded dialysis-provider coverage |
| Jul 29 | Earnings date | Neutral | -2.2% | Scheduled Q2 financial results and corporate update conference call |
| Jun 08 | Patent ruling | Positive | +2.1% | Federal Circuit affirmed patent validity and permanent generic-product injunction |
| May 15 | Investor conferences | Neutral | -4.8% | Participation in RBC Capital Markets and Jefferies healthcare conferences |
| May 14 | Q1 earnings | Positive | +5.7% | Raised 2026 revenue and EBITDA guidance alongside positive Phase III results |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive earnings and patent announcements aligned with gains, while the prior investor-conference notice diverged with a -4.79% reaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be participating in a fireside chat and investor meetings at the upcoming Wells Fargo 21st Annual Healthcare Conference being held in Boston on September 8 – 10, 2026.
| Wells Fargo 21st Annual Healthcare Conference | |
| Date: Time: Webcast: | Wednesday, September 9, 2026 12:45pm EDT Click here |
A replay of the fireside chat will also be available in the “Presentations and Events” page on the investor relations portion of the Company’s website at: www.cormedix.com
About CorMedix
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: www.cormedix.com.
Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
